Drug application
REGROTON (CHLORTHALIDONE, RESERPINE)
Drugs@FDA NDA 015103 · SANOFI AVENTIS US
Key facts
| Drug name | REGROTON |
|---|---|
| Active ingredients | CHLORTHALIDONE, RESERPINE |
| Application type | NDA |
| Application number | 015103 |
| Company | SANOFI AVENTIS US |
| Dosage forms | TABLET, ORAL |
| Strength | 50MG;0.25MG |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission class | Type 4 - New Combination |
| Latest submission status date | May 8, 1964 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.